Active surveillance is in many cases the best option in order to guarantee the highest possible quality of life for patients diagnosed with prostate cancer.
The Prostate Unit at the CCC is organised into a multidisciplinary team which devises and monitors treatment plans specific to each clinical situation.
This team of specialists, which includes medical oncologists, urologists, radiotherapists, radiologists, pathologists, nuclear medicine specialists, nurses, psycho-oncologists and nutritionists, addresses the disease at each stage in order to offer personalized diagnosis, treatment, advice and rehabilitation.
Even though prostate cancer is the most frequent malignant tumour in men, and the third highest cause of death from cancer, it regularly exhibits a slow growth. In its more aggressive forms however it can grow quickly, invading the adjacent organs, and metastasising particularly to the lymphatic glands and bones. For this reason, the CCC has created a programme of cancer risk assessment and early diagnosis where our experienced team strives to detect tumours which are still in the initial phase of development. This early diagnosis of the disease permits a timely therapeutic intervention and ensures a greater probability of success in the improvement of the quality of life of the patient and a reduced mortality.
It is in this context of early diagnosis that our programme of active surveillance is particularly important in the development of new strategies to combat prostate cancer. Depending on the risk of tumour progression, the treatment decision may be based around a plan of regular monitoring without any associated therapy or surgical intervention. Alternatively, the plan may indicate the immediate initiation of multidisciplinary treatment. Our team of specialists is committed to offering the best advice and, in the active surveillance of patients, looking for the most appropriate solutions in each case.
In addition to prostate cancer, we also treat cancers of the kidney and urinary tract in this unit.
Source: Informação sobre a incidência e mortalidade por cancro em Portugal, “Globocan 2008”, International Agency for Research on Cancer, World Health Organization.